Fig. 4
Viability of MDA-MB-468 (A) and A-375 (B) cells after treatment with solid-lipid nanoparticle without EO (free SLNs), Z. multiflora EO (ZMEO), and solid-lipid nanoparticle containing the EO (ZMSLN). ***Significant difference (P < 0.001)
Fig. 4 | BMC Pharmacology and Toxicology